Pelvic Floor Trainers and Apps: What the Evidence Does Not Say

No consumer pelvic floor trainer and no app appears anywhere in the guidelines, systematic reviews or trials this site is built on, which means nobody can give you a success rate for one, including the manufacturers. That is not the same as evidence they do not work. It means the question has not been answered in the sources used here, and any page that hands you a percentage for a device has either found evidence this site has not, or invented it.

I want to be honest about my own history with this, because I am not writing from a position of scepticism I earned cheaply. In the three years I spent being told that leaking when I ran was normal after two babies, I downloaded an app. It reminded me three times a day, it kept a streak, and I did what it told me for months. Nothing changed. When I was finally assessed, the reason was not that I had been lazy. It was that I had been doing the wrong movement, diligently, for a very long time, and no reminder in the world fixes that. The app was not the villain. It was just answering a question I had not been asked yet. For what the treatment involves once somebody has, see pelvic floor physiotherapy.

What the absence actually is

It is total, and it is worth stating precisely rather than vaguely. The evidence base behind pelvic health physiotherapy is built on supervised programmes: the Cochrane review that produced the strongest result in the field covers 31 trials and 1,817 women and compares pelvic floor muscle training against no treatment, placebo, sham or another inactive control, finding cure in 56% of women with stress urinary incontinence against 6% of controls, a risk ratio of 8.38 with a 95% confidence interval of 3.68 to 19.07, graded high certainty from 4 trials and 165 women¹.

Read what that compared. Training against nothing. It is not a comparison of a device against no device, or of an app against a leaflet, and nobody may borrow its numbers for a product. The guideline dose is equally free of hardware: NICE says programmes should comprise at least 8 contractions performed 3 times per day, a recommendation tagged [2006] because it was carried forward unchanged rather than re-reviewed in the 2019 update². Not one word of it is about equipment.

What these products claim, and what is actually known about unsupervised training

Most claim some combination of three things: that they will teach you the movement, that they will measure it, and that they will keep you doing it. The first two are the contested ones.

The closest thing to a verdict in this site’s sources is not about devices but about supervision, and it goes in a consistent direction. There is Level 1, Grade A evidence that pelvic floor muscle training is effective in the treatment of stress urinary incontinence, with short-term cure rates assessed as less than 2 g of leakage on pad testing varying between 35% and 80%, and supervised and more intensive training is more effective than unsupervised training; the same source states that training needs proper instruction and close follow-up to be effective³. That 35% to 80% spread is what happens when different trials define cure differently, and the supervision finding is the part a product has to argue against rather than around.

The three things a device would have to do to replace an assessment

None of which any of them does, and the reasons are structural rather than a matter of build quality.

• It would have to tell you which problem you have. A weak pelvic floor and an overactive one can produce overlapping symptoms and their treatments run in opposite directions. No consumer device makes that distinction, and getting it wrong is not a neutral outcome.
• It would have to tell a correct contraction from bearing down. This is the specific failure mode the evidence documents. In 47 women referred for urodynamic evaluation of urinary incontinence, only 49% achieved an ideal contraction after brief standardised verbal instruction and 25% performed a technique that could potentially promote incontinence⁴. The counterweight belongs in the same paragraph: among 779 women in community primary care practices, between 68.6% and 85.8% contracted correctly on the first attempt depending on symptoms, and 78% of those who got it wrong learned after brief instruction⁵. Most people get it right; the people who do not are concentrated among those who already have symptoms, and a pressure reading rising because somebody is straining downwards looks a great deal like progress on a screen.
• It would have to review and progress a dose. NICE requires at least one review to assess progress during a supervised programme and one review at the end⁶. A device that gives you the same target in week 16 as in week 1 is not delivering a programme, it is delivering a metronome. How a real dose changes over a course is in pelvic floor exercise programmes explained, and what the target movement even is is in how to do a pelvic floor contraction correctly.

What a device or an app can plausibly do

Prompt, count, record and make an invisible thing feel less abstract. That is a modest job and it is not a worthless one, because the thing that most often fails in this treatment is not the physiology.

A systematic review of 19 studies following 1,141 women for between 1 and 15 years found long-term adherence to training ranging from 10% to 70%, with long-term success among the original responders ranging from 41% to 85%⁷. If a prompt at eight in the morning moves somebody from the bottom of that adherence range to the middle of it, that is a real contribution. The same review contains the finding that stops this becoming a sales pitch: short-term outcomes could be maintained at long-term follow-up without incentives for continued training⁷. Adherence falls, and the benefit does not fall as far as you would expect. Keeping it up after discharge is the longer version of that argument.

The safety point that matters most here

A strengthening device sold to somebody with an overactive pelvic floor is the wrong treatment in a box. For a hypertonic floor the muscle is failing to switch off rather than failing to switch on, and conventional strengthening can make symptoms worse. Pain-led presentations sit disproportionately in that group, and they are exactly the readers most likely to buy something in frustration after a long wait.

The breadth of what a pelvic floor symptom can turn out to be is the reason a product cannot triage it. NICE NG210 covers women aged 12 and over across urinary incontinence, bladder emptying disorders, faecal incontinence, bowel emptying disorders, pelvic organ prolapse, sexual dysfunction and chronic pelvic pain, which is seven distinct presentations sharing one anatomical region⁶. A device that responds to all seven with the same instruction to squeeze harder is not tailoring anything.

This is the one place where the unassessed use of a device carries a specific, foreseeable cost, and it is why every strengthening page on this site links to hypertonic pelvic floor and downtraining. The rule is simple and it does not require a clinician to apply: if training is making your symptoms worse rather than better, that is a reason to be reassessed, not a reason to do more of it with better equipment. If anything on the list in red flags and when to stop and get checked applies to you, none of this is the right next step at all.

What the money buys instead

Start with the framing that reorders the whole comparison: there is no official price for this treatment anywhere. The Chartered Society of Physiotherapy states in its own position paper that competition law prevents it, in line with all other professional bodies, from seeking to negotiate rates for private practitioners⁸. So the private figures below are aggregations and surveys, labelled as such, not a price list.

Aggregating UK clinic price lists gives roughly £75 to £150 for an initial assessment and £60 to £120 for a follow-up, with pelvic health typically at the upper end. The nearest published general figures come from the HMDG Private Practice Barometer 2026, an independent commercial survey of clinic owners fielded between August and November 2025, which reported a median of £74 for an initial appointment and £63 for a follow-up across all physiotherapy. In the UK the same treatment is free at the point of use on the NHS, which itself notes there may be a long waiting list⁹. The full picture across five health systems is in how much does pelvic health physiotherapy cost.

The comparison worth making is not device against appointment as though they did the same job. It is that one assessment establishes which treatment you need, and no quantity of equipment does. If cost is the barrier rather than preference, getting referred to pelvic health physiotherapy is the more useful page.

If you already have one

Take it to your appointment. A clinician can tell you in about a minute whether what it measures corresponds to what your muscle is doing, and that single answer is worth more than any review, including this one. NICE specifies that programmes should be supervised by a physiotherapist or other healthcare professional with the appropriate expertise in pelvic floor muscle training⁶, and a device used inside that relationship is a different object from the same device used instead of it.

What would change this page is straightforward: a trial of a named product against supervised training, with a stated definition of cure and a stated population, in a source of the standard the rest of this site uses. If that appears, this article gets rewritten around it. Until then the useful sentence is the one I wish somebody had said to me in year one, which is that no product can answer a question nobody has asked about you yet. Start with what happens at a pelvic health physio assessment, and if equipment does turn up in your treatment, biofeedback and electrical stimulation covers what it is doing there.